Cargando…
The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany
BACKGROUND: Real-word evidence from diverse data sources is increasingly important in terms of generating rapid insights to effectively manage patient populations, especially during major public health disruptions such as the ongoing COVID-19 pandemic. Patients with chronic and inflammatory diseases...
Autores principales: | Orschiedt, Jonathan, Jacyshyn-Owen, Elizabeth, Kahn, Maria, Jansen, Sven, Joschko, Natalie, Eberl, Markus, Schneeweiss, Sebastian, Friedrich, Benjamin, Ziemssen, Tjalf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756211/ https://www.ncbi.nlm.nih.gov/pubmed/36527843 http://dx.doi.org/10.1016/j.biopha.2022.114129 |
Ejemplares similares
-
Demographic Patterns of MS Patients Using BRISA: An MS-Specific App in Germany
por: Balakrishnan, Preetha, et al.
Publicado: (2022) -
Correlation and differences of patient-reported outcomes vs.
Likert-Rating of MS symptoms in a real-world cohort using a digital patient
app
por: Mountford, Steffeni, et al.
Publicado: (2023) -
The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany
por: Kahn, Maria, et al.
Publicado: (2023) -
Real-world demographic patterns of users of a digital primary prevention service for diabetes
por: Balakrishnan, Preetha, et al.
Publicado: (2022) -
Patient satisfaction and healthcare services in specialized multiple sclerosis centres in Germany
por: Becker, Veit, et al.
Publicado: (2018)